Do we have a "game changer" in treating patients with brain metastasis from renal cell carcinoma?
- PMID: 32016078
- PMCID: PMC6976467
- DOI: 10.21037/atm.2019.09.50
Do we have a "game changer" in treating patients with brain metastasis from renal cell carcinoma?
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.J Clin Oncol. 2019 Aug 10;37(23):2008-2016. doi: 10.1200/JCO.18.02218. Epub 2019 Jun 13. J Clin Oncol. 2019. PMID: 31194611 Clinical Trial.
Similar articles
-
Waking rest: a game changer or a name changer?Sleep. 2019 Oct 9;42(10):zsz172. doi: 10.1093/sleep/zsz172. Sleep. 2019. PMID: 31595967 No abstract available.
-
Gemcitabine: a game changer in nasopharyngeal carcinoma.Lancet. 2016 Oct 15;388(10054):1853-1854. doi: 10.1016/S0140-6736(16)31394-0. Epub 2016 Aug 23. Lancet. 2016. PMID: 27567280 No abstract available.
-
Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: a potential game changer toward global standardization of care.Hepatobiliary Surg Nutr. 2017 Jun;6(3):203-204. doi: 10.21037/hbsn.2017.04.02. Hepatobiliary Surg Nutr. 2017. PMID: 28653006 Free PMC article. No abstract available.
-
Aerogenous metastases: a potential game changer in the diagnosis and management of primary lung adenocarcinoma.AJR Am J Roentgenol. 2014 Dec;203(6):W570-82. doi: 10.2214/AJR.13.12088. AJR Am J Roentgenol. 2014. PMID: 25415722 Review.
-
The "glymphatic" mechanism for solute clearance in Alzheimer's disease: game changer or unproven speculation?FASEB J. 2018 Feb;32(2):543-551. doi: 10.1096/fj.201700999. Epub 2018 Jan 3. FASEB J. 2018. PMID: 29101220 Free PMC article. Review.
Cited by
-
Tumor-to-Tumor Metastasis of Lung Cancer to Kidney Cancer: A Review of the Literature and Our Experience.Diagnostics (Basel). 2024 Mar 5;14(5):553. doi: 10.3390/diagnostics14050553. Diagnostics (Basel). 2024. PMID: 38473025 Free PMC article. Review.
-
The Construction and Validation of a new Predictive Model for Overall Survival of Clear Cell Renal Cell Carcinoma Patients with Bone Metastasis Based on Machine Learning Algorithm.Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231165131. doi: 10.1177/15330338231165131. Technol Cancer Res Treat. 2023. PMID: 37078130 Free PMC article. Clinical Trial.
-
Fatal tumoral hemorrhage from brain metastases of renal cell carcinoma after stereotactic radiotherapy and immune checkpoint inhibitor and vascular endothelial growth factor-targeted therapy combinations.IJU Case Rep. 2024 Mar 4;7(3):225-229. doi: 10.1002/iju5.12708. eCollection 2024 May. IJU Case Rep. 2024. PMID: 38686061 Free PMC article.
-
Identification of a Risk Stratification Model to Predict Overall Survival and Surgical Benefit in Clear Cell Renal Cell Carcinoma With Distant Metastasis.Front Oncol. 2021 Mar 11;11:630842. doi: 10.3389/fonc.2021.630842. eCollection 2021. Front Oncol. 2021. PMID: 33777784 Free PMC article.
-
Metastatic Kidney Cancer: Does the Location of the Metastases Matter? Moving towards Personalized Therapy for Metastatic Renal Cell Carcinoma.Biomedicines. 2024 May 16;12(5):1111. doi: 10.3390/biomedicines12051111. Biomedicines. 2024. PMID: 38791072 Free PMC article. Review.
References
-
- Vickers MM, Al-Harbi H, Choueiri TK, et al. Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium. Clin Genitourin Cancer 2013;11:311-5. 10.1016/j.clgc.2013.04.012 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources